Bacterial resistance in acne

Dermatology

Volumn 196, Issue 1, 1998, Pages 59-66

  Eady, E A ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Acne therapy; Clindamycin; Coagulase negative staphylococci; Cutaneous propionibacteria; Erythromycin; Resistance; Tetracycline

Indexed keywords

ANTIBIOTIC AGENT; ERYTHROMYCIN;

ACNE; ANTIBIOTIC RESISTANCE; BACTERIUM CARRIER; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG USE; EUROPE; HUMAN; JAPAN; NEW ZEALAND; POPULATION DENSITY; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; RISK BENEFIT ANALYSIS; SKIN FLORA; UNITED STATES;

ACNE VULGARIS; ANTI-BACTERIAL AGENTS; COAGULASE; DRUG RESISTANCE, MICROBIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; PROPIONIBACTERIUM; SKIN; STAPHYLOCOCCUS;

EID: 0031905659     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017869     Document Type: Conference Paper

References (28)

1. Eady EA, Ingham E: Propionibacterium acnes - Friend or foe? Rev Med Microbiol 1994;5:163-173.
2. Eady EA, Holland KT, Cunliffe WJ: The use of antibiotics in acne therapy: Oral or topical administration? J Antimicrob Chemother 1982;10:89-115.
3. Miller YW, Eady EA, Lacey RW, Cove JH, Joanes DN, Cunliffe WJ: Sequential antibiotic therapy for acne promotes the carriage of resistant staphylococci on the skin of contacts. J Antimicrob Chemother 1996;38:829-837.
4. Marples RR, Kligman AM: Ecological effects of oral antibiotics on the microflora of human skin. Arch Dermatol 1971;103:148-153.
5. Leyden JJ, Marples RR, Mills OH, Kligman AM: Tretinoin and antibiotic therapy in acne vulgaris. South Med J 1974;67:20-25.
6. Eady EA, Cove JH, Holland KT, Cunliffe WJ: Superior antibacterial action and reduced incidence of bacterial resistance in minocycline compared to tetracycline-treated acne patients. Br J Dermatol 1990;122:233-244.
7. Vowels BR, Feingold DS, Sloughfy C, Foglia AN, Konnikov N, Ordoukhanian E, Starkey P, Leyden JJ: Effects of topical erythromycin on ecology of aerobic cutaneous bacterial flora. Antimicrob Agents Chemother 1996;40:2598-2604.
8. Harkaway KS, McGinley KJ, Foglia AN, Lee W-L, Fried F, Shalita AR, Leyden JJ: Antibiotic resistance patterns in coagulase-negative staphylococci after treatment with topical erythromycin, benzoyl peroxide and combination therapy. Br J Dermatol 1992;126:586-590.
9. Eady EA, Farmery MR, Ross JI, Cove JH, Cunliffe WJ: Effects of benzoyl peroxide and erythromycin alone and in combination against antibiotic-sensitive and -resistant skin bacteria from acne patients. Br J Dermatol 1994;131:331-336.
10. Gemmell CG, McCartney AC: Coagulase-negative staphylococci within the hospital environment. Rev Med Microbiol 1990;1:213-218.
11. Kloos WE, Bannerman TL: Update on clinical significance of coagulase-negative staphylococci. Clin Microbiol Rev 1994;7:117-140.
12. Eady EA, Cove JH, Holland KT, Cunliffe WJ: Erythromycin-resistant propionibacteria in antibiotic-treated acne patients: Association with therapeutic failure. Br J Dermatol 1989;121:51-57.
13. Bojar RA, Eady EA, Jones CE, Cunliffe WJ, Holland KT: Inhibition of erythromycin-resistant propionibacteria on the skin of acne patients by topical erythromycin with and without zinc. Br J Dermatol 1994;130:329-336.
14. Eady EA, Bojar RA, Jones CE, Cove JH, Holland KT, Cunliffe WJ: The effects of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin-resistant propionibacteria. Br J Dermatol 1996;134:107-113.
15. Farmery MR, Jones CE, Eady EA, Cove JH, Cunliffe WJ: In vitro activity of azelaic acid, benzoyl peroxide and zinc acetate against antibiotic-resistant propionibacteria from acne patients. J Dermatol Treat 1994;5:63-65.
16. Guin JD, Lummins WL: Comedonal levels of free clindamycin following topical treatment with a 1% solution of clindamycin phosphate. J Am Acad Dermatol 1982;7:265-268.
17. Gardner KJ, Cunliffe WJ, Eady EA, Cove JH: Variation in comedonal antibiotic concentrations following application of topical tetracycline for acne vulgaris. Br J Dermatol 1994;131:649-654.
18. Layton AM, Hughes BR, Macdonald Hull S, Eady EA, Cunliffe WJ: Seborrhoea - An indicator for poor clinical response in acne patients treated with antibiotics. Clin Exp Dermatol 1992;17:173-175.
19. Crawford WW, Crawford IP, Stoughton RB, Cornell RC: Laboratory induction and clinical occurrence of combined clindamycin and erythromycin resistance in Corynebacterium acnes. J Invest Dermatol 1979;72:187-190.
20. Eady EA, Jones CE, Tipper JL, Cove JH, Cunliffe WJ, Layton AM: Antibiotic-resistant propionibacteria in acne: Need for policies to modify antibiotic usage. Br Med J 1993;306:555-556.
21. Forssman T: Antibiotikaresistenzen beachten. Therapiewoche 1993;43:2248-2252.
22. Kurokawa I, Nishijima S, Asada Y: The antibiotic susceptibility of Propionibacterium acnes: A 15-year bacteriological study and retrospective evaluation, J Dermatol 1988;15:149-154.
23. Oakley A, Rademaker M, Duffill M, Leng R, Shewan J: Propionibacterium: Resistance of acne to antibiotics. NZ Med J 1995;108:43-44.
24. Leyden JJ, McGinley KJ, Cavalieri S, Webster GF, Mills OH, Kligman AM: Propionibacterium acnes resistance to antibiotics in acne patients. J Am Acad Dermatol 1983;8:41-45.
25. Eady EA, Ross JI, Cove JH, Holland KT, Cunliffe WJ: Macrolide-lincosamide-streptogramin B (MLS) resistance in cutaneous propionibacteria: Definition of phenotypes. J Antimicrob Chemother 1989;23:493-502.
26. Ross JI, Eady EA, Cove JH, Jones CE, Ratyal AH, Miller YW, Vyakrnam S, Cunliffe WJ: Clinical resistance to erythromycin and clindamycin in cutaneous propionibacteria isolated from acne patients is associated with mutations in 23S rRNA. Antimicrob Agents Chemother 1997;41:1162-1165.
27. Eady EA, Jones CE, Gardner KJ, Taylor JP, Cove JH, Cunliffe WJ: Tetracycline-resistant propionibacteria from acne patients are cross-resistant to doxycycline but sensitive to minocycline. Br J Dermatol 1993;128:556-560.
28. Eady EA, Ross JI, Cove JH, Holland KT, Cunliffe WJ: The effects of oral erythromycin therapy for acne on the development of resistance in cutaneous staphylococci and propionibacteria; in Marks R, Plewig G (eds): Acne and Related Disorders. London, Dunitz, 1989, pp 265-270.